Want to create an interactive transcript for this episode?
Podcast: Agbioscience
Episode: 350. Elevate Ventures’ Matt Tyner on the cost of innovation + the role of the investor in this next era of venture capital
Description: Pitchbook reports that of venture capital deals in 2024, roughly 30% of them were down rounds or flat, meaning their valuation of the companies either went backwards or were the same round to round. It’s a trend that will continue, so how can entrepreneurs break the cycle? Matt Tyner, managing partner of America’s most active venture capital firm – Elevate Ventures, joins today to make sense of what’s ahead and how innovators can succeed. He gets into:  The current state of venture capital – and the criticality of taking a step back to understand where things sit today In...